Neuromediators in cutaneous immunobiology;LES NEUROMEDIATEURS EN IMMUNOBIOLOGIE CUTANEE

Nouvelles Dermatologiques

Volumn 15, Issue 1, 1996, Pages 28-33

  Staniek, V ^a   Misery, L ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

immunobiology; Langerhans cells; neuromediator; skin; substance P

Indexed keywords

BOMBESIN; CALCITONIN GENE RELATED PEPTIDE; ENKEPHALIN; NERVE GROWTH FACTOR; NEUROPEPTIDE; NEUROTENSIN; SEROTONIN; SOMATOSTATIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

HUMAN; IMMUNE SYSTEM; KERATINOCYTE; LANGERHANS CELL; REVIEW; SKIN;

EID: 0029912330     PISSN: 07525370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Pincelli C., Fantini F., Massimi P., Giannetti A. Neuropeptide Y-like immunoreactivity in Langerhans cells from patients with atopic dermatitis. Int. J. Neurosci. 1990; 51: 219-220.
2. Johansson O. A detailed account of NPY-imnmnoreactive nerves and cells of the human skin. Comparison with VIP, substance P and PHI-containing structures. Acta Physiol Scand. 1986; 128: 147-153.
3. Dalsgaard C., Jonsson C., Hökfelt T., Cuello A. Localization of substance P-immunoreactive nerve fibers in the human digital skin. Experientia 1983; 39: 1018-1020.
4. Vega J., Haro J., De Lamo A., Ordieres M. et al. Distribution of low affinity nerve growth factor receptor (NGFr) immunoreactivity in the human digital skin. Eur. J. Dermatol. 1992; 2: 509-516.
5. Fantini F., Johansson O. Expression of growth-associated protein 43 and nerve growth factor receptor in human skin: a comparative immunohistochemical investigation. J. Invest. Dermatol. 1992; 99: 734-742.
6. Karanth S., Springall D., Kuhn D., Levene M et al. An immunocytochemical study of cutaneous innervation and the distribution of neuropeptides and protein gene product 9.5 in man and commonly employed laboratory animals. Am. J. Anat. 1991; 191: 369-383.
7. Björklund H., Dalsgaard C., Jonsson C., Hermansson A. Sensory and autonomic innervation of non-hairy and hairy human skin. Cell Tissue Res. 1986; 243: 51-57.
8. Dalsgaard C., Rydh M., Haegerstrand A. Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry 1989; 92: 385-389.
9. Pernow B. Role of tachykinins in neurogenic inflammation. J. Immunol. 1985; 135: 812s-815s.
10. Foreman J. Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int. Arch. Allergy Appl. Immunol. 1987; 82: 366-371.
11. Fuller R , Conradson T., Dixon C., Crossman D. et al. Sensory neuropeptide effects in human skin. Br. J. Pharmacol. 1987; 92: 781-788.
12. Piotrowski W., Foreman JC. Some effects of calcitonin generelated peptide in human skin and on histamine release . Br. J. Dermatol. 1986; 114: 37-46.
13. Wallengren J., Hakanson R. Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses. Eur. J. Pharmacol. 1987; 143: 267-273.
14. Matsuda H., Kawakita., Kiso Y., Nakano T. et al. Substance P induces granulocyte infiltration through degranulation of mast cells. J. Immunol. 1989; 142: 927-931.
15. Foreman J. Peptides and neurogenic inflammation. Br. Med. Bull. 1987; 43: 386-400.
16. Nikkels-Tassoudji N., Nikkels AF., Pierard GE. Neuropeptides cutanés. Nouv. Dermatol. 1994; 13: 767-772.
17. Misery L., Campos L., Sabido O., Kanitakis J. et al. S100 protein and neuron-specific enolase on monocytic leukemic CD1+ cells, probable precursors of Langerhans cells. Eur. J. Haematol. 1993; 51: 132-135.
18. Fantini F., Pincelli C., Sevignani C., Baraldi A. et al. Langerhans cells can express neuron-specific enolase immunoreactivity. Arch. Dermatol. Res. 1991; 283: 10-12.
19. Gaudillere A., Misery L., Souchier C., Schmitt D. et al. Intimate associations between Langerhans cells and epidermal nerve fibers. J. Invest. Dermatol. 1994; 103: 452 (a332).
20. Hosoi J., Murphy G.F., Egan CL., Lerner EA, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature. 1993; 363: 159-163.
21. Misery L., Staniek V., Peguet-Navarro J., Sabido O. et al. Expression of Gastrin Releasing Peptide-receptor in human skin. J. Invest. Dermatol. 1995; 105: 500 (aP234).
22. Staniek V., Misery L., Abello J., Peguet-Navarro J. et al. Human Langerhans cells express SP receptors. J. Invest Dermatol. 1995; 105: aP235 sous presse.
23. Morheen VB., Stage K., Lee S. Activated human Langerhans cells contain mRNA for Proopiomelanocortin. J. Invest. Dermatol. 1994; 94: 557 (a).
24. Bhardwaj RS., Luger TA. Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis. Arch. Dermatol. Res. 1994; 287. 85-90.
25. Johansson O., Vaalasti A., Billiges M., Ljungberg A. et al. Somatostatin-like immunoreactivity in human dendritic cells with special reference to Langerhans cells of the skin. In: The Langerhans cell. J. Thivolet, D. Schmitt Eds. Colloque INSERM. John Libbey Eurotext Ltd. 1988; 172: 261-271.
26. Hilliges M., Wang L., Johansson O. Ultrastructural evidence for nerve fibers within all vital layers of the human epidermis. J. Invest. Dermatol. 1995; 104: 134-137.
27. Leong J., Goeltz E., Goldstein SM. Identification of neuropeptide receptors in skin. J. Invest. Dermatol. 1994; 102: 636 (a674).
28. Haegerstrand A., Jonzon B., Dalsgaard C., Nilsson J. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA. 1989; 86: 5993-5996.
29. Kemeny L., Von Restoff B., Michel G., Ruzicka T. Specific binding and lack of growth-promoting activity of Substance P in cultured human keratinocytes. J. Invest. Dermatol. 1994; 103: 605-606.
30. Arenberger P., Leder RO., Abraham A., Chang JK. et al. Substance P binding in normal neonatal foreskin. Br J Dermatol. 1995; 132: 54-58.
31. Takahashi K., Nakanishi S., Imamuro S. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NMY through G protein-coupled receptors. J. Invest Dermatol. 1993: 101: 646-651.
32. Mac Govern UB., Jones KT., Sharpe GR. Intracellular calcium as a second messenger following growth stimulation of human keratinocytes. Br. J. Dermatol. 1995; 132: 892-896.
33. Tanaka T., Danno K., Ikai K., Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J. Invest. Dermatol. 1988; 90: 399-401.
34. Schauer E., Trautinger F., Keck A., Schwarz A. et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. J. Clin. Invest. 1994; 93: 2258-2262.
35. Pincelli C., Sevignani C., Manfredini R., Grande A. et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol. 1994: 103: 13-18.
36. Segura JJ., Guerrero JM., Goberna R., Calvo JR. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Pegul. Pept. 1991; 33: 133-143.
37. Goldman R., Bar-Shavit Z., Romeo D. Neurotensin modulates human neutrophil locomotion and phagocytic capability. FEBS Lett. 1983; 159: 63-67.
38. Bar-Shavit Z., Terry S., Blumberg S., Goldman R. Neurotensinmacrophage interaction: specific binding and augmentation of phagocytosis. Neuropeptides. 1982; 2: 325-335.
39. De la Fuente M., Garrido JJ., Arahuetes RM., Hernanz A. Stimulation of phagocytic function in mouse macrophages by neurotensin and neuromedin. N.J. Neuroimmunol. 1993; 42: 97-104.
40. Goetzl EJ., Patel DR., Kishiyama JL., Smoll AC. et al. Specific Recognition of the Human Neuroendocrine Receptor for Vasoactive Intestinal Peptide by Anti-Peptide Antibodies. Mol Cell Neurosci. 1994; 5: 145-152.
41. - Sternberg EM., Trial J., Parker CW. Effect of serotonin on murine macrophages: suppression of la expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J. Immunol. 1986; 137: 276-282.
42. Hartung HP., Wolters K., Toyka KV. Substance P: Binding properties and studies on cellular responses in guinea pig macrophages. J. Immunol. 1986; 136: 3856-3863.
43. Kimball ES., Persico FJ., Vaught JL. Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. J.Immunol. 1988; 141: 3564-3569.
44. Del Rio M., Hernanz A., De la Fuente M. Bombesin, Gastrin-releasing Peptide, and Neuromedin C modulate Murine lymphocyte proliferation through adherent accessory cells and activate protein kinase C. Peptides. 1994; 15: 15-22.
45. Lemaire I. Neurotensin enhances IL-1 production by activated alveolar macrophages. J.Immunol. 1988; 140: 2983-2988.
46. Fabry Z., Raine CS., Hart MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today. 1994; 15: 218-224.
47. Johnston JA., Taub DD., Lloyd AR., Conlon K. et al. Human T lymphocyte chemotaxis and adhesion induced by Vasoactive Intestinal Peptide. J. Immunol. 1994; 153: 1762-1768.
48. Roberts AI., Panja A., Brolin RE., Ebert EC. Human intraepithelial lymphocytes: Immunomodulation and receptor binding of vasoactive intestinal peptide. Dig. Dis. Sci. 1991; 36: 341-346.
49. Wenger GD., O'Dorisio MS., Goetzl EJ. Vasoactive intestinal peptide. Messenger in a neuroimmune axis. Ann. N. Y. Acad. Sci. 1990; 594: 104-119.
50. Malec P., Zeman K., Markiewicz K., Tchorzewski II. et al. Short-term somatostatin infusion affects T lymphocyte responsiveness in humans. Immunopharmacology 1989; 17: 45-49.
51. Rameshwar P., Gascon P., Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J. Immunol. 1993; 151: 2484-2496.
52. Thorpe LW., Jerrells TR., Perez-Polo JR. Mechanism of lymphocyte activation by nerve growth factor. Ann. N. Y. Acad. Sci. 1990; 594: 78-84.
53. Payan DG., Goeltz EJ. Modulation of lymphocytes functions by sensory neuropeptides. J.Immunol. 1985; 135: 783s-786s.
54. Boudard F., Bastide M. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis. J. Neurosci. Res 1991; 29: 29-41
55. Stanisz AM., Befus D , Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol. 1986; 136: 152-156
56. Jin G., Guo Y., Smith ER., Houston CW. The effect of bombesin-related peptides on the phagocytic function of mouse phagocytes in vitro. Peptides. 1990; 11: 393-396.
57. Morley JE., Kay NE., Solomon GF., Plotnikoff N.P. Neuropeptides: cConductors of the immune orchestra. Life Sci. 1987; 41: 527-544.
58. Johnson HM., Downs MO., Pontzer CH. Neuroendocrine peptide regulation of immunity, in Neuroimmunoendocrinilogy 2nd edition. 1992; 22: 49-83. K Ishizava, PJ Lachmann, BH Waksman Eds JE Blablock.
59. Jones JM., James H., Mansour M. Neuropeptide Y modulates T Cell proliferation in vitro. Ann. N. Y. Acad. Sci. 1990; 594: 388-390.
60. McGillis J., Mitsuhashi M., Payan DG. Immunomodulation by tachykinin neuropeptides. Ann. N. Y. Acad Sci. 1990; 594: 85-94.
61. Wang F., Millet I., Bottomly K., Vignery A. Calcitonin generelated peptide inhibits interleukine 2 production by murine T-lymphocytes. J. Biol. Chem. 1992; 267: 21052-21057.
62. Ottaway CA., Husband AJ. The influence of neuroendocrine pathways on lymphocyte migration. Immunol. Today. 1994; 15: 511-517.
63. Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA. 1989; 86: 10059-10063.
64. Wagner F., Fink R., Hart R., Dancygier H. Substance P enhances IFN-γ production by human peripheral blood mononuclear cells. Regul. Pept. 1987; 19: 335-364.
65. Sirianni MC., Tagliaferri F., Fais S., Annibale B. et al. Effect of Vasoactive Intestinal Peptide neuropeptide on natural killer activity from peripheral blood lymphocytes of normal subjects. Ann. N. Y. Acad. Sci. 1990; 594: 420-423.
66. Hellstrand K., Herdmonsson S. Monocyte-mediated suppression of IL-2-induced NK-cell activation. Regulation by 5-HT1A-type serotonin receptors. Scand. J. Immunol. 1990; 32: 183-192.
67. Hellstrand K., Hermodsson S. Serotoninergic S-HT1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes. Scand. J. Immunol. 1993; 37: 7-18.
68. Madhavan PNN., Scwartz SA., Wu K., Kroufol Z. Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain, Behaviour and Immunity. 1993; 7: 70-78.
69. Lebranchu Y. Allergies cutanées: un mastocyte bien particulier. Nouv. Dermatol. 1993; 12: 592-595.
70. Walsh LJ., Trinchieri G., Waldorf HA., Whitaker D. et al. Human dermal mast cells contain and release tumor necrosis factor alpha with induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 1991; 88: 4220-4224.
71. Cochrane DE., Carraway RE., Boucher W., Feldberg RS. Rapid degradation of neurotensin by stimulated rat mast cells. Peptides. 1991; 12: 1187-1194.
72. Hafstrom I., Ringertz B., Lundeberg T., Palmblad J. The effect of endothelin, neuropeptide Y, calcitonin gene-related peptide and substance P on neutrophil functions. Acta Physiol. Scand. 1993; 148: 341-346.
73. O'Dorisio MS., Wood CL., O'Dorisio TM. Vasoactive intestinal peptide and neuropeptide modulation of the immune response. J. Immunol. 1985; 135: 792s-796s
74. O'Dorisio MS. Biochemical characteristics of receptors for vasoactive intestinal polypeptide in nervous, endocrine, and immune systems. Fed. Proc. 1987; 46: 192-195.
75. Pincelli C., Fantini F., Massimi P., Girolomoni G., et al. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br. J. Dermatol. 1990; 122: 745-750.
76. Fantini F., Pincelli C., Romualdi P., Donatini A., et al. Substance P levels are decreased in lesional skin of atopic dermatitis. Exp. Dermatol. 1992; 1: 126-128.
77. Eedy DJ., Johnston CF., Shaw C., Buchanan KD. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J. Invest. Dermatol. 1991; 96: 434-438.
78. Anand P., Springall DR., Blank MA., Sellu D. et al. Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br. J. Dermatol. 1991; 124: 547-549.
79. Giannetti A., Girolomoni G. Skin reactivity to neuropeptides in atopic dermatitis. Br. J. Dermatol. 1989; 121: 681-688.
80. Heyer G., Hornstein O., Handwerker II. Reactions to intradermally injected substance P and topically applied mustard oil in atopic dermatitis patients. Acta Derm. Venereol. 1991; 71: 291-295.
81. Paul C., Chosidow O., Frances C. La capsaïcine en dermatologie. Ann. Dermatol. Vénéréol. 1993; 120: 563-570.